MARK2 and breast carcinoma: Protein kinase C (PKC) is a family of serine/threonine kinases that regulate signalling pathways associated with proliferation, invasion and metastasis and have been implicated in the progression of various cancer entities, including breast cancer, while its role in mediating chemoresistance remains largely unknown [23, 24].